Glioma Clinical Trials in Fairfax, Virginia

4 studies are recruiting for glioma in Fairfax, Virginia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

    The purpose of this study is to see if combining silevertinib with temozolomide after surgery and radiotherapy helps treat newly diagnosed glioblastoma (GBM) better than using temozolomide alone in the maintenance setting. Specifically, this study is being done to find answers to the following ques…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Inova Schar Cancer Institute, Fairfax, Virginia
    Locations
    30 in total
    Run by
    Black Diamond Therapeutics, Inc.

    See if you can join NCT07326566 on ClinicalTrials.gov

  2. SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

    This is a 3-part study. The purpose of Part 1 of the study is to evaluate the efficacy, safety, and pharmacokinetic (PK) characteristics of safusidenib in participants with recurrent/progressive IDH1-mutant World Health Organization (WHO) Grade 2 or Grade 3 glioma. The purpose of Part 2 will be to …

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Inova Schar Cancer Institute, Fairfax, Virginia
    Locations
    61 in total
    Run by
    Nuvation Bio Inc.

    See if you can join NCT05303519 on ClinicalTrials.gov

  3. A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

    This is a two-part Phase 1, open label, multi-center, single arm, non-randomized, multiple dose, safety, pharmacokinetic (PK) and preliminary efficacy study of single agent NST-628 in adult patients with MAPK pathway mutated/dependent advanced solid tumors who have exhausted standard treatment opti…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    NEXT Oncology - Virginia, Fairfax, Virginia
    Locations
    23 in total
    Run by
    Nested Therapeutics, Inc

    See if you can join NCT06326411 on ClinicalTrials.gov

  4. ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)

    This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study in patients with newly diagnosed H3 K27M-mutant diffuse glioma to assess whether treatment with dordaviprone (ONC201) following frontline radiotherapy will extend overall survival and progression-fr…

    Stage
    Phase 3
    Ages
    Any age
    Site
    Inova Schar Cancer Institute, Fairfax, Virginia
    Locations
    162 in total
    Run by
    Jazz Pharmaceuticals

    See if you can join NCT05580562 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.